These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30175868)

  • 1. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
    Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
    Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
    Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
    Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
    Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tripartite Motif-Containing Protein 59 (TRIM59) Promotes Epithelial Ovarian Cancer Progression via the Focal Adhesion Kinase(FAK)/AKT/Matrix Metalloproteinase (MMP) Pathway.
    Zhang P; Zhang H; Wang Y; Zhang P; Qi Y
    Med Sci Monit; 2019 May; 25():3366-3373. PubMed ID: 31062766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
    Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
    PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
    Chen B; Wang J; Dai D; Zhou Q; Guo X; Tian Z; Huang X; Yang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 May; 36(1):65. PubMed ID: 28494797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of tripartite motif protein 59 inhibits proliferation, migration and invasion in breast cancer cells.
    Zhang Y; Yang WB
    Biomed Pharmacother; 2017 May; 89():462-467. PubMed ID: 28249247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.
    Lin F; Xie YJ; Zhang XK; Huang TJ; Xu HF; Mei Y; Liang H; Hu H; Lin ST; Luo FF; Lang YH; Peng LX; Qian CN; Huang BJ
    J Exp Clin Cancer Res; 2019 Apr; 38(1):152. PubMed ID: 30961661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models.
    Valiyeva F; Jiang F; Elmaadawi A; Moussa M; Yee SP; Raptis L; Izawa JI; Yang BB; Greenberg NM; Wang F; Xuan JW
    Mol Cancer Ther; 2011 Jul; 10(7):1229-40. PubMed ID: 21593385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
    Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
    Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
    Dong Q; Fu L; Zhao Y; Tan S; Wang E
    Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma.
    Liang J; Xing D; Li Z; Shen J; Zhao H; Li S
    Mol Med Rep; 2016 Jun; 13(6):5200-6. PubMed ID: 27121462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM59 promotes cell proliferation, migration and invasion in human hepatocellular carcinoma cells.
    Sun G; Sui X; Han D; Gao J; Liu Y; Zhou L
    Pharmazie; 2017 Nov; 72(11):674-679. PubMed ID: 29442042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM59 promotes gefitinib resistance in EGFR mutant lung adenocarcinoma cells.
    Cui Z; Liu Z; Zeng J; Zhang S; Chen L; Zhang G; Xu W; Song L; Guo X
    Life Sci; 2019 May; 224():23-32. PubMed ID: 30902544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA8 inhibits cell apoptosis via AKT signaling and is associated with poor prognosis in breast cancer.
    Wang GH; Ni K; Gu C; Huang J; Chen J; Wang XD; Ni Q
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.